Details

NameSymbolSector
NECTAR LIFESCIENCES LIMITEDNECLIFEPharmaceuticals
Open
10.2
High
10.54
Low
10.1
Close
10.54
Volume
171958
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

2

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Nectar Lifesciences is  
Closing Marubozu
Estimated Stoploss of Nectar Lifesciences is ₹  
10.1
Nectar Lifesciences has a  
Bullishℹ
 pattern. 
Formation of  
Closing Marubozu
 candle pattern indicates Nectar Lifesciences has chances of  
Continuationℹ
 of the current trend. 

Trend

Nectar Lifesciences is in  
Sideways trendℹ
. 
Price of Nectar Lifesciences is  
Downℹ
 by  

3.13

%. 
Target
Buy @ 

9.61

Sell @ 

12.31

Current @ 

10.54

Volume

The trade volumes of Nectar Lifesciences have been  
Underperformingℹ
The volume trend for Nectar Lifesciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Nectar Lifesciences is  

Up

 by  

2.42

% 

Valuation

The current market price of Nectar Lifesciences is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 2047cr and total assets worth ₹ 2047cr, the balance sheet of Nectar Lifesciences is:  
Balancedℹ
. 
Cashflow
Nectar Lifesciences has  
Poorℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

100

%. 

(*Mar 2025)

50% i.e. ₹ 169cr earned in operatingℹ
12.13% i.e. ₹ 41cr spent in investingℹ
37.87% i.e. ₹ 128cr spent in financingℹ
0% in otherℹ
Nectar Lifesciences has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2024)

50.22% i.e. ₹ 224cr earned in operatingℹ
3.81% i.e. ₹ 17cr spent in investingℹ
45.96% i.e. ₹ 205cr spent in financingℹ
0% in otherℹ
Income
The income of Nectar Lifesciences is  

₹ 5cr

 and  

Loss

 is :  

₹ 176cr

(*Sep 2025)

Nectar Lifesciences Losses increased by:  

179.37

% and Income is Down by:  

98.22

% 

(*Sep 2025)

The income of Nectar Lifesciences is  

₹ 281cr

 and  

Loss

 is :  

₹ 63cr

(*Jun 2025)

Nectar Lifesciences Losses decreased by:  

51.54

% and Income is Down by:  

34.65

% 

(*Jun 2025)

The income of Nectar Lifesciences is  

₹ 430cr

 and  

Loss

 is :  

₹ 130cr

(*Mar 2025)

Nectar Lifesciences Losses increased by:  

1957.14

% and Income is Down by:  

5.49

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.